View All Key Stats
INCY Key Stats
| Income Statement | |
| Revenue (TTM) | 941.24M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 0.38 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 74.07M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 94.98% |
| Profit Margin (Quarterly) | 13.98% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0.00 |
| Price and Valuation | |
| Market Cap | 16.73B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 18.53 |
| PE Ratio (TTM) | 234.16 |
| Price to Book Value | 56.31 |
| Other | |
| Beta | Upgrade |
| Debt to Equity Ratio (Quarterly) | 2.139 |
| Free Cash Flow (Quarterly) | -64.64M |
| Return on Equity (TTM) | 44.09% |
View All INCY News
INCY News
-
WireHeadlineTime (ET)
-
Yahoo09/21 11:34
-
Yahoo09/20 08:14
-
Yahoo09/19 15:00
-
PR Newswire09/15 17:01
-
Yahoo09/09 10:56
-
Yahoo09/09 09:41
-
Business Wire09/08 09:00
-
Yahoo09/07 09:21
-
Yahoo09/07 08:28
-
Yahoo09/06 08:04
View All Events
INCY Events
| Date | Type | Description |
|---|---|---|
| 08/09/2016 10:00 EDT | Misc | Incyte Corp Second Quarter Earnings Conference Call in 2016 |
| 08/09/2016 | Earnings | Incyte Corp Second Quarter Earnings in 2016 Release |
| 05/09/2016 10:00 EDT | Misc | Incyte Corp First Quarter Earnings Conference Call in 2016 |
| 05/09/2016 | Earnings | Incyte Corp First Quarter Earnings in 2016 Release |
| 05/09/2016 | Misc | Incyte and Ariad Announce Agreement for Incyte to Acquire Ariad’s European Operations and In-license Iclusigâ® (Ponatinib) in Europe |
| 02/11/2016 10:00 EST | Misc | Incyte Corp Fourth Quarter Earnings Conference Call in 2015 |
| 02/11/2016 | Earnings | Incyte Corp Fourth Quarter Earnings in 2015 Release |
| 11/03/2015 10:00 EST | Misc | Incyte Corp Third Quarter Earnings Conference Call in 2015 |
| 11/03/2015 | Earnings | Incyte Corp Third Quarter Earnings in 2015 Release |
INCY Fundamentals
Income Statement View Statement
INCY Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
One Page Reports
- One Page Report Download
Edit
Profile
- URL: http://www.incyte.com
- Investor Relations URL: http://investor.incyte.com/phoenix.zhtml?c=69764&p=irol-irhome
- HQ State/Province: Delaware
- Sector: Healthcare
- Industry: Biotechnology
- Next Earnings Release: N/A
- Last Earnings Release: August 09, 2016
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Incyte Corp is a biopharmaceutical company. It discovers, develops and commercializes proprietary small molecule drugs to treat serious unmet medical needs, mainly in oncology.
INCY Comparables
EditINCY Excel Add-In Codes
- Name: =YCI("INCY","name")
- Description: =YCI("INCY","description")
- Sector: =YCI("INCY","sector")
- Industry: =YCI("INCY","industry")
- Est. Current Fiscal Year End: =YCI("INCY","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other INCY Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- INCY Tweets Stocktwits
Advertisement